Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
403 | 3443 | 44.5 | 89% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | RANKL | Author keyword | 220 | 38% | 14% | 465 |
2 | OSTEOCLAST | Author keyword | 188 | 24% | 20% | 681 |
3 | OSTEOCLASTOGENESIS | Author keyword | 98 | 35% | 7% | 227 |
4 | OSTEOPROTEGERIN | Author keyword | 56 | 21% | 7% | 232 |
5 | OSTEOCLASTS | Author keyword | 55 | 19% | 8% | 267 |
6 | NFATC1 | Author keyword | 47 | 45% | 2% | 78 |
7 | OPG | Author keyword | 40 | 29% | 3% | 115 |
8 | OSTEOCLAST DIFFERENTIATION | Author keyword | 37 | 45% | 2% | 62 |
9 | BONE RESORPTION | Author keyword | 35 | 12% | 8% | 277 |
10 | RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B LIGAND | Author keyword | 31 | 38% | 2% | 64 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | RANKL | 220 | 38% | 14% | 465 | Search RANKL | Search RANKL |
2 | OSTEOCLAST | 188 | 24% | 20% | 681 | Search OSTEOCLAST | Search OSTEOCLAST |
3 | OSTEOCLASTOGENESIS | 98 | 35% | 7% | 227 | Search OSTEOCLASTOGENESIS | Search OSTEOCLASTOGENESIS |
4 | OSTEOPROTEGERIN | 56 | 21% | 7% | 232 | Search OSTEOPROTEGERIN | Search OSTEOPROTEGERIN |
5 | OSTEOCLASTS | 55 | 19% | 8% | 267 | Search OSTEOCLASTS | Search OSTEOCLASTS |
6 | NFATC1 | 47 | 45% | 2% | 78 | Search NFATC1 | Search NFATC1 |
7 | OPG | 40 | 29% | 3% | 115 | Search OPG | Search OPG |
8 | OSTEOCLAST DIFFERENTIATION | 37 | 45% | 2% | 62 | Search OSTEOCLAST+DIFFERENTIATION | Search OSTEOCLAST+DIFFERENTIATION |
9 | BONE RESORPTION | 35 | 12% | 8% | 277 | Search BONE+RESORPTION | Search BONE+RESORPTION |
10 | RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B LIGAND | 31 | 38% | 2% | 64 | Search RECEPTOR+ACTIVATOR+OF+NUCLEAR+FACTOR+KAPPA+B+LIGAND | Search RECEPTOR+ACTIVATOR+OF+NUCLEAR+FACTOR+KAPPA+B+LIGAND |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | OSTEOPROTEGERIN LIGAND | 318 | 48% | 14% | 488 |
2 | RECEPTOR ACTIVATOR | 251 | 31% | 20% | 675 |
3 | LYMPH NODE ORGANOGENESIS | 137 | 78% | 3% | 90 |
4 | KAPPA B LIGAND | 123 | 27% | 11% | 395 |
5 | OSTEOCLAST DIFFERENTIATION FACTOR | 121 | 45% | 6% | 204 |
6 | DIFFERENTIATION FACTOR | 113 | 32% | 8% | 290 |
7 | OSTEOCLASTOGENESIS INHIBITORY FACTOR | 112 | 48% | 5% | 173 |
8 | RANKL | 110 | 37% | 7% | 235 |
9 | BONE RESORPTION | 91 | 13% | 19% | 640 |
10 | NFATC1 | 65 | 64% | 2% | 63 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Osteoclast differentiation and activation | 2003 | 2089 | 72 | 82% |
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems | 2007 | 460 | 114 | 61% |
Functions of RANKL/RANK/OPG in bone modeling and remodeling | 2008 | 310 | 93 | 61% |
The molecular understanding of osteoclast differentiation | 2007 | 387 | 134 | 57% |
Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab | 2012 | 80 | 139 | 46% |
Osteocyte control of osteoclastogenesis | 2013 | 34 | 84 | 55% |
Bone resorption by osteoclasts | 2000 | 1562 | 51 | 59% |
RANKL-RANK signaling in osteoclastogenesis and bone disease | 2006 | 331 | 74 | 62% |
Biology of the RANKL-RANK-OPG system in immunity, bone, and beyond | 2014 | 9 | 132 | 64% |
Immunology and bone | 2013 | 26 | 82 | 61% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IMAGING SCI BASED LUNG BONE DIS | 15 | 63% | 0.4% | 15 |
2 | REGULAT BONE METAB DIS | 14 | 65% | 0.4% | 13 |
3 | SKELETAL DIS | 10 | 44% | 0.5% | 17 |
4 | TAKAYANAGI OSTEONETWORK PROJECT | 8 | 46% | 0.4% | 13 |
5 | BK21PLUS PROGRAM | 6 | 80% | 0.1% | 4 |
6 | NAGAHAMA BIOCHEM SCI | 5 | 34% | 0.3% | 12 |
7 | BONE MINERAL DIS | 5 | 13% | 1.0% | 35 |
8 | PHYSIOPATHOL ORPT OSSEUSE THER IE TUMEU | 5 | 23% | 0.5% | 18 |
9 | MED GENE REGULAT | 4 | 20% | 0.6% | 20 |
10 | EXPLORAT ADV TECHNOL ERATO PROGRAM | 4 | 67% | 0.1% | 4 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000199139 | OSTEOPROTEGERIN//VASC MED ATHEROTHROMBOSIS//INTERDEPARTMENTAL REGENERAT MED |
2 | 0.0000127609 | TARTRATE RESISTANT ACID PHOSPHATASE//SPECIAL HEMATOL//TARTRATE RESISTANT |
3 | 0.0000106907 | PL BENCH CORE//ANTIDIARRHEIC//DRIED PLUM |
4 | 0.0000106039 | OSTEOPETROSIS//MALIGNANT INFANTILE OSTEOPETROSIS//TCIRG1 |
5 | 0.0000097896 | CATHEPSIN K//PYCNODYSOSTOSIS//CATHEPSIN K INHIBITOR |
6 | 0.0000094263 | LONGEV SCI//HOSP GERIATR MED//TORAT MED |
7 | 0.0000075892 | POSITIVE BONE BALANCE//PROSTAGLANDIN ESTRADIOL PGE2//ENDOCRINOL METAB MC1850 |
8 | 0.0000067932 | ASEPTIC LOOSENING//WEAR DEBRIS//OSTEOLYSIS |
9 | 0.0000064644 | MYELOMA BONE DISEASE//CAM DR//HEIM |
10 | 0.0000064279 | AROMATASE DEFICIENCY//MALE OSTEOPOROSIS//INTEGRATED MED ENDOCRINOL METAB GERIATR |